2025 United States Allografts Market Revenue Opportunities Report
Description
The 2025 United States Allografts Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allografts Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the United States allografts market are MTF Biologics, RTI Surgical, Zimmer Biomet, and Stryker. MTF Biologics offers the largest selection of allograft tissues in the U.S., with over 1,000 graft types and a robust supply chain featuring 48 academic members and federally designated recovery organizations. RTI Surgical provides a broad product portfolio in sports medicine and reconstructive surgery, manufacturing allograft soft tissue and bone grafts, with multiple manufacturing sites in the U.S. Zimmer Biomet and Stryker are leading players in bone allografts and orthopedic implants, commanding a significant market share due to extensive product portfolios and ongoing strategic acquisitions.
Zimmer Biomet, headquartered in Indiana, is the largest global knee and hip implant manufacturer, generating $7.7 billion revenue in 2024, focusing on product innovation and acquisitions like Paragon 28 to expand extremity product lines. Stryker, with a market focus on mergers and acquisitions, leverages its extensive commercial infrastructure to grow sales in orthopedics, including allografts. Both Zimmer Biomet and Stryker hold dominant positions in the U.S. bone graft substitutes and implant market, which is strictly regulated by the FDA to ensure product safety and efficacy. Together, these four companies shape the competitive landscape of the U.S. allografts market by driving innovation, supply chain integration, and product availability.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allografts Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the United States allografts market are MTF Biologics, RTI Surgical, Zimmer Biomet, and Stryker. MTF Biologics offers the largest selection of allograft tissues in the U.S., with over 1,000 graft types and a robust supply chain featuring 48 academic members and federally designated recovery organizations. RTI Surgical provides a broad product portfolio in sports medicine and reconstructive surgery, manufacturing allograft soft tissue and bone grafts, with multiple manufacturing sites in the U.S. Zimmer Biomet and Stryker are leading players in bone allografts and orthopedic implants, commanding a significant market share due to extensive product portfolios and ongoing strategic acquisitions.
Zimmer Biomet, headquartered in Indiana, is the largest global knee and hip implant manufacturer, generating $7.7 billion revenue in 2024, focusing on product innovation and acquisitions like Paragon 28 to expand extremity product lines. Stryker, with a market focus on mergers and acquisitions, leverages its extensive commercial infrastructure to grow sales in orthopedics, including allografts. Both Zimmer Biomet and Stryker hold dominant positions in the U.S. bone graft substitutes and implant market, which is strictly regulated by the FDA to ensure product safety and efficacy. Together, these four companies shape the competitive landscape of the U.S. allografts market by driving innovation, supply chain integration, and product availability.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
